Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1. This update is a UI/version label change and does not alter study content or functionality.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 has been added, replacing the previous v3.4.0. This appears to be a minor, non-user-facing update with no visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdditions include a glossary toggle display and new metadata labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page, a minor metadata change not affecting study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with a Catalonia subsection and updated the page revision to v3.3.3. Removed the separate Catalonia Locations grouping and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a minor system update and does not alter core study details, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.